Eagle Pharmaceuticals Announces Commencement of Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Eagle Pharmaceuticals (EGRX) 1.3M Offering Priced at $42/Share
March 17, 2015 9:04 AM EDTEagle Pharmaceuticals, Inc. (Nasdaq: EGRX) today announced the pricing of an underwritten public offering of 1,320,276 shares of its common stock at a price to the public of $42.00 per share. 1,190,476 shares are being sold by Eagle and 129,800 shares are being sold by certain stockholders of the... More
Eagle Pharmaceuticals (EGRX) Commences $50M Stock Offering
March 16, 2015 4:36 PM EDTEagle Pharmaceuticals, Inc. (Nasdaq: EGRX) today announced that it has commenced an underwritten public offering, subject to market and other conditions, to issue and sell approximately $50,000,000 of shares of its common stock. In addition, certain stockholders of the Company (the Selling Stockholders) are offering... More
